Search

Search Constraints

You searched for: Author/Creator Gilletta, Cyrielle

Search Results

1. Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study. (2nd December 2022)

2. Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID. Issue 10 (5th April 2021)

3. Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real‐world cohort study. Issue 11 (14th April 2020)

4. Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study. (8th September 2020)

5. Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study. Issue 7 (23rd July 2021)

6. Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy. Issue 1 (15th May 2020)

7. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Issue 1 (January 2023)

8. Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID. (2nd September 2022)

9. Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation. (17th November 2020)

10. Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study. (13th January 2020)